Search

Your search keyword '"Haynes, Barton F"' showing total 2,398 results

Search Constraints

Start Over You searched for: Author "Haynes, Barton F" Remove constraint Author: "Haynes, Barton F"
2,398 results on '"Haynes, Barton F"'

Search Results

1. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies

2. Discovery and characterization of a pan-betacoronavirus S2-binding antibody

4. The other pandemic: lessons from 40 years of HIV research

5. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

6. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

7. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes

9. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques

11. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice

13. Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor

15. Contributors

16. HIV-1 Vpu restricts Fc-mediated effector functions in vivo

17. Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike

18. Structural diversity of the SARS-CoV-2 Omicron spike

19. Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials

20. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice

22. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

24. Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity

25. SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition

27. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies

30. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

31. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge

33. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

35. Computational analysis of antibody dynamics identifies recent HIV-1 infection

36. Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors

37. Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

39. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

40. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

43. Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge

44. Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization

45. Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.

46. A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals

47. Microsecond dynamics control the HIV-1 Envelope conformation

48. Cold sensitivity of the SARS-CoV-2 spike ectodomain

49. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

50. Contribution of proteasome-catalyzed peptide cis -splicing to viral targeting by CD8⁺ T cells in HIV-1 infection

Catalog

Books, media, physical & digital resources